Katherine Gambill
Family · Las Vegas, NVNPI 1215681127
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Novo Nordisk at 27.4% of the total. Among family clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $24.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$534
- AstraZeneca$483
- Exact Sciences$318
- ANI Pharmaceuticals, Inc.$226
- Astellas Pharma US Inc$158
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,141100%
- Entertainment$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $1,141 |
| Lilly USA, LLC | 26 | $534 |
| AstraZeneca | 10 | $483 |
| Exact Sciences | 12 | $318 |
| ANI Pharmaceuticals, Inc. | 5 | $226 |
| Astellas Pharma US Inc | 4 | $158 |
| AbbVie | 3 | $152 |
| Amgen | 6 | $147 |
| Abbott | 2 | $144 |
| Pfizer | 8 | $143 |
| Intra-sana Laboratories | 9 | $138 |
| Bayer | 4 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $66 |
| Viiv Healthcare Company | 2 | $57 |
| Dexcom, Inc. | 3 | $56 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| Antares Pharma, Inc. | 3 | $45 |
| Novartis | 2 | $34 |
| Boehringer Ingelheim | 1 | $31 |
| Merck | 1 | $26 |
| Mylan Specialty L.p. | 1 | $22 |
| Impel Pharmaceuticals Inc. | 1 | $19 |
| GSK | 1 | $16 |
| Optos, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$240
- FARXIGA$125
- Saxenda$125
- PURIFIED CORTROPHIN GEL$125
- Veozah$125
- FREESTYLE LIBRE 3$120
- Wegovy$119
- RYBELSUS$118
- The Cologuard Plus Collection Kit$117
- QULIPTA$115
How this compares
$4,157 in reported general payments places this provider in the 90th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 23 | $206 |
| Levothyroxine Sodium | 13 | $158 |
| Amlodipine Besylate | 19 | $134 |
| Lisinopril | 15 | $117 |
| Alprazolam | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other family in Las Vegas
- Hollie TylerLas Vegas$118K
- John PhoenixLas Vegas$107K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
- Erin WilkinsonLas Vegas$43K
- Anna Melisa Lopez-SanglayLas Vegas$42K
- Kelly PapeshLas Vegas$28K
- Bernard BlanksLas Vegas$26K
- Hillary DursteinLas Vegas$21K
- Victoria HughesLas Vegas$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.